Regulators' strategies for managing the surge in cell and gene therapies Commercializing Living Therapies with CCRM

Featuring:Michael Rosu-Myles, PhD, Executive Director, Health CanadaJosephine Lembong, PhD, Senior Manager, Science and Industry Affairs, Alliance for Regenerative Medicine***Currently, there are more than 2,000 cell and gene therapies in clinical trials worldwide. With a goal of ensuring that safe and quality products are approved for use by patients, regulators determine whether these innovative therapies move from the lab to market.In this interview, Michael Rosu-Myles, PhD, Executive Dire...